Web Exclusives

In patients with HR-positive breast cancer, a positive circulating tumor cells assay result was associated with nearly a 20-fold increased risk for recurrence of disease.

Older women with hormone receptor–positive, HER2-negative metastatic breast cancer who are treated with a CDK4/6 inhibitor may derive benefits similar to those seen in their younger counterparts.

Treatment with a regimen of pembrolizumab plus trastuzumab in patients with trastuzumab-resistant advanced HER2-positive breast cancer was well-tolerated and had clinical benefit in those whose tumors were positive for a biomarker for pembrolizumab.

Patients under age 40 with breast cancer who underwent axillary lymph node dissection were more likely to experience arm swelling and decreased range of arm motion than patients who received less invasive sentinel lymph node biopsies.

According to the results of 2 recent analyses, dose-dense or dose-intense chemotherapy reduces the risk for breast cancer recurrence and improves survival compared with standard chemotherapy regimens.

February is National Cancer Prevention Month! Check out this slideshow full of information relating to the detection and prevention of cancer, including the 4 leading causes of cancer in the US. Conquer cancer with knowledge.

Do cell phones cause cancer? Does deodorant cause breast cancer? These common myths and more explored in this slideshow.

For the first time in 40 years, patients who are considering reconstructive surgery after a mastectomy because of breast cancer have a new option for tissue expansion—the AeroForm Tissue Expander System.